AUSTER MARTIN (Chief Financial Officer) sold 37.0% of their position (28K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $970.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/7/2023ACC: 0001209191-23-035224
Officer· Chief Financial Officer
Since Oct 2021
-28K
Net shares
Net seller
$970.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
28K acquired · 56K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+28K
Price / share
$3.45
Trade value
$96.60K
% of position
58.8%
6/6/2023
47.65K→75.65K
Common Stock
Direct
Shares
−24.25K
Price / share
$34.59
Trade value
$838.78K
% of position
32.1%
6/6/2023
75.65K→51.40K
Common Stock
Direct
Shares
−3.75K
Price / share
$34.95
Trade value
$131.18K
% of position
7.3%
6/6/2023
51.40K→47.65K
Total
Net shares
+0.00
Net value
-$873.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2023 | M · Option Exercise | +28K | $3.45 | $96.60K | 58.8% | 47.65K | 75.65K |
| Common Stock Direct | 6/6/2023 | S · Sale | −24.25K | $34.59 | $838.78K | 32.1% | 75.65K | 51.40K |
| Common Stock Direct | 6/6/2023 | S · Sale | −3.75K | $34.95 | $131.18K | 7.3% | 51.40K | 47.65K |
| Total | +0.00 | -$873.36K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
28K shares
Shares
−28K
Strike price
3.45
Held after
247.18K
Exercisable
—
6/6/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock28K shares | 6/6/2023 | M · Option Exercise | −28K | 3.45 | — | 247.18K |